Dengue Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Dengue Fever Pipeline Drugs Market Report Overview
Dengue is a mosquito borne infectious disease caused by the dengue virus. Symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. In some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from nose, gums, or under skin. It can also become dengue shock syndrome, which causes massive bleeding and shock. Treatment includes use of analgesics, fluid replacement therapy and healthy life style.
The dengue fever pipeline drugs market research report provides comprehensive information on the dengue fever targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in dengue fever targeted therapeutics development with respective active and dormant or discontinued projects.
Dengue Fever Pipeline Drugs Market Segmentation by Target
The key targets in the dengue fever pipeline drugs market are Envelope Protein, Nonstructural Protein 4B, Nonstructural Protein 5, Nonstructural Protein 1, Nonstructural Protein 3, and Premembrane Protein among others. Envelope Protein, Nonstructural Protein 4B, and Nonstructural Protein 5 have the highest number of dengue fever drugs in development in 2022.
Dengue Fever Pipeline Drugs Market Analysis, by Target
For more target insights on dengue fever pipeline drugs market, download a free report sample
Dengue Fever Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanisms of action of the dengue fever pipeline drugs market are Nonstructural Protein 4B Inhibitor, Nonstructural Protein 5 Inhibitor, Envelope Protein Inhibitor, Nonstructural Protein 3 Inhibitor, Toll Like Receptor 4 Antagonist, and Aryl Hydrocarbon Receptor Antagonist among others. Nonstructural Protein 4B Inhibitor and Nonstructural Protein 5 Inhibitor led the dengue fever pipeline drugs market in 2022.
Dengue Fever Pipeline Drugs Market Analysis, by Mechanisms of Action
For more MoA insights on the dengue fever pipeline drugs market, download a free report sample
Dengue Fever Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the dengue fever pipeline drugs market are subcutaneous, oral, intramuscular, intravenous, intradermal, nasal, parenteral, and transdermal. Subcutaneous is the most preferred RoA in the dengue fever pipeline drugs market.
Dengue Fever Pipeline Drugs Market Analysis, by Routes of Administration
For more RoA insights dengue fever pipeline drugs market, download a free report sample
Dengue Fever Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the dengue fever pipeline drugs market are small molecule, live attenuated vaccine, subunit vaccine, monoclonal antibody, vaccine, and recombinant vector vaccine among others. Small molecule leads the dengue fever pipeline drugs market in this segment.
Dengue Fever Pipeline Drugs Market Analysis, by Molecule Types
To know more about the molecule types in the dengue fever pipeline drugs market, download a free report sample
Dengue Fever Pipeline Drugs Market - Competitive Landscape
The leading companies in the dengue fever pipeline drugs market are Takeda Pharmaceutical Co Ltd, BioNet-Asia Co Ltd, Emergex Vaccines Holding Ltd, Johnson & Johnson, 60 Degrees Pharmaceuticals LLC, and Abivax SA among others. Takeda Pharmaceutical Co Ltd has the highest number of dengue fever drugs in development in 2022.
Dengue Fever Pipeline Drugs Market Analysis, by Companies
To know more about the leading dengue fever pipeline drugs market players, download a free report sample
Dengue Fever Pipeline Drugs Market Overview
Key Target | Envelope Protein, Nonstructural Protein 4B, Nonstructural Protein 5, Nonstructural Protein 1, Nonstructural Protein 3, and Premembrane Protein |
Key Mechanisms of Action | Nonstructural Protein 4B Inhibitor, Nonstructural Protein 5 Inhibitor, Envelope Protein Inhibitor, Nonstructural Protein 3 Inhibitor, Toll Like Receptor 4 Antagonist, and Aryl Hydrocarbon Receptor Antagonist |
Key Routes of Administration | Subcutaneous, Oral, Intramuscular, Intravenous, Intradermal, Nasal, Parenteral, and Transdermal |
Key Molecule Types | Small Molecule, Live Attenuated Vaccine, Subunit Vaccine, Monoclonal Antibody, Vaccine, and Recombinant Vector Vaccine |
Leading Companies | Takeda Pharmaceutical Co Ltd, BioNet-Asia Co Ltd, Emergex Vaccines Holding Ltd, Johnson & Johnson, 60 Degrees Pharmaceuticals LLC, and Abivax SA |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Dengue Fever (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Dengue Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Dengue Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Dengue Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Dengue Fever (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Dengue Fever (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Dengue Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Abhelix LLC
Abivax SA
AbViro LLC
Acer Therapeutics Inc
Atea Pharmaceuticals Inc
Avida Biotech SL
Biological Mimetics Inc
BioNet-Asia Co Ltd
Biotron Ltd
Bugworks Research Inc
Cidara Therapeutics Inc
Codagenix Inc
Decoy Therapeutics Inc
Emergex Vaccines Holding Ltd
Ennaid Therapeutics LLC
Etna Biotech Srl
Excivion Ltd
Exopharm Ltd
Globavir Biosciences Inc
Greffex Inc
Hercules Pharmaceuticals BV
HSRx Group
ImmuneMed Inc
Immunotope Inc
Imutex Ltd
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Integral Molecular Inc
Island Pharmaceuticals Ltd
Johnson & Johnson
KARE Biosciences Inc
KinoPharma Inc
KM Biologics Co Ltd
Mabloc LLC
Macrophage Therapeutics Inc
Medigen Inc
Meletios Therapeutics SAS
Moleculin Biotech Inc
Najit Technologies Inc
NanoViricides Inc
Novartis AG
Panacea Biotec Ltd
Plex Pharmaceuticals Inc
ProtInhi BV
ReVacc Biotech
Riboscience LLC
Seagull BioSolutions Pvt Ltd
Serum Institute of India Pvt Ltd
Shionogi & Co Ltd
Sun Pharma Advanced Research Company Ltd
Takeda Pharmaceutical Co Ltd
TechnoVax Inc
TenGen Biomedical Co
Theravectys SA
TrippBio Inc
Uvax Bio LLC
Vir Biotechnology Inc
Virocovax
Visterra Inc
VLP Therapeutics LLC
Xenothera SAS
Zucero Therapeutics Ltd
Zydus Lifesciences Ltd
Table of Contents
Frequently asked questions
-
What are the key target areas in the dengue fever pipeline drugs market?
The key targets in the dengue fever pipeline drugs market are Envelope Protein, Nonstructural Protein 4B, Nonstructural Protein 5, Nonstructural Protein 1, Nonstructural Protein 3, and Premembrane Protein among others.
-
What are the key mechanisms of action in the dengue fever pipeline drugs market?
The key mechanisms of action in the dengue fever pipeline drugs market are Nonstructural Protein 4B Inhibitor, Nonstructural Protein 5 Inhibitor, Envelope Protein Inhibitor, Nonstructural Protein 3 Inhibitor, Toll Like Receptor 4 Antagonist, and Aryl Hydrocarbon Receptor Antagonist.
-
What are the key routes of administration in the dengue fever pipeline drugs market?
The key routes of administration in the dengue fever pipeline drugs market are subcutaneous, oral, intramuscular, intravenous, intradermal, nasal, parenteral, and transdermal.
-
What are the key molecule types in the dengue fever pipeline drugs market?
The key molecule types in the dengue fever pipeline drugs market are small molecule, live attenuated vaccine, subunit vaccine, monoclonal antibody, vaccine, and recombinant vector vaccine among others.
-
Which are the leading companies in the dengue fever pipeline drugs market?
Some of the leading companies in the dengue fever pipeline drugs market are Takeda Pharmaceutical Co Ltd, BioNet-Asia Co Ltd, Emergex Vaccines Holding Ltd, Johnson & Johnson, 60 Degrees Pharmaceuticals LLC, and Abivax SA among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Infectious Disease reports

